Drug Trial Radar · NCT06698003
A Study of Mogamulizumab to Prevent Adult T-cell Leukemia/Lymphoma in People With HTLV-1
Last checked: Nov 20, 2026Latest source record: Mar 5, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
134
Planned (sponsor's estimate)
Start
Nov 15, 2024
Primary completion
Nov 15, 2029
Study completion Nov 15, 2029
Sponsor
- Lead sponsor
- Memorial Sloan Kettering Cancer CenterAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Nov 20, 2024
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Non randomized
- Model
- Sequential
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to find out whether the study drug mogamulizumab is effective in preventing the development of adult T-cell leukemia/lymphoma (ATL) in people who are at higher risk for this type of cancer because they are infected with the HTLV-1 virus and because of changes seen in some of their immune system cells called T-cells.
Conditions
- T-Cell Leukemia/Lymphoma, Adult
- T-cell Leukemia/Lymphoma
- T-cell Leukemia
- Lymphoma
Interventions
MogamulizumabDrug
Cohort 1: 0.3 mg/kg of mogamulizumab every 12 weeks, for 2 total doses Cohort 2: 0.3 mg/kg of mogamulizumab every 6 weeks, for 4 total doses
Primary outcomes
What the sponsor says the trial is designed to measure.
- Minimum dose and schedule of mogamulizumab to reduce the proviral load by ≥75%Time frame: 6 months from baseline
Locations
7 sites in 1 country. Site status is shown where the registry gives one.
Memorial Sloan Kettering at Basking Ridge (All protocol activities)
Basking Ridge, New Jersey · Recruiting
Memorial Sloan Kettering Monmouth (All protocol activities)
Middletown, New Jersey · Recruiting
Memorial Sloan Kettering Bergen (All Protocol Activities)
Montvale, New Jersey · Recruiting
Memorial Sloan Kettering Cancer Center @ Suffolk-Commack (All protocol activities)
Commack, New York · Recruiting
Memorial Sloan Kettering Westchester (All protocol activities)
Harrison, New York · Recruiting
Memorial Sloan Kettering Cancer Center (All Protocol Activities)
New York, New York · Recruiting
Memorial Sloan Kettering Nassau (All protocol activities)
Uniondale, New York · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.